In menopause, reduced estrogen levels disrupt this equilibrium—enhancing resorption through increased receptor activator of nuclear factor kappa-β ligand (RANKL) and decreased osteoprotegerin—contributing to osteoporosis. This evidence concerns the gene TNFSF11 and osteoporosis.